Latest Asx News

Saunders International appoints Angelo De Angelis as CEO effective October 2025, succeeding Mark Benson who will support the transition through 2026. This leadership change signals a steady hand guiding the company’s next growth phase.

Trading in the Nanuk New World Fund (Currency Hedged) Active ETF has been temporarily halted, with personal trading also paused as investors await further details.

Beacon Minerals has released the final batch of assay results from its extensive Stage 2 drill program at the Iguana Deposit, revealing multiple high-grade gold intersections and validating historical data. These findings set the stage for an updated Mineral Resource Estimate later this year.

CAQ Holdings Limited reported a 29.6% revenue decline and a 43.9% increase in net loss for the half-year ended June 2025, driven largely by falling investment property values and ongoing liquidity challenges.

Wellnex Life has secured a significant opening order from global partner Haleon for its Liquid Paracetamol and Ibuprofen softgel products in the UAE, marking the fourth national market in Haleon's distribution network. This milestone supports Wellnex's revenue forecasts for 2025 and underscores its strategic focus on innovative healthcare products.

SPDR S&P/ASX 200 ETF (STW) has announced an estimated ordinary dividend of AUD 0.836278 per security for the quarter ending 30 September 2025, with a Dividend Reinvestment Plan available to investors.

Thrive Tribe Technologies is raising up to A$618,736 through a discounted entitlement offer to existing shareholders in Australia, New Zealand, and Malaysia. The capital raise aims to bolster working capital and cover offer expenses.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

Terra Metals has intersected a 58-metre thick titano-magnetite reef at its Southwest Prospect, marking the thickest reef found to date within the Dante Project and significantly expanding its resource potential.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.

Emyria secures a multi-year funding agreement with Medibank to support its Treatment-Resistant Depression program, marking a first for insurer-backed psychotherapy in Australia.